Journal article
Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): Protocol of a randomised controlled trial
B Temple, NT Toan, DY Uyen, A Balloch, K Bright, YB Cheung, P Licciardi, CD Nguyen, NTM Phuong, C Satzke, H Smith-Vaughan, TQH Vu, TN Huu, EK Mulholland
BMJ Open | BMJ PUBLISHING GROUP | Published : 2018
Abstract
Introduction WHO recommends the use of pneumococcal conjugate vaccine (PCV) as a priority. However, there are many countries yet to introduce PCV, especially in Asia. This trial aims to evaluate different PCV schedules and to provide a head-to-head comparison of PCV10 and PCV13 in order to generate evidence to assist with decisions regarding PCV introduction. Schedules will be compared in relation to their immunogenicity and impact on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Methods and analysis This randomised, single-blind controlled trial involves 1200 infants recruited at 2 months of age to one of six infant PCV schedules: PCV10 in a 3+1, 3+0, 2+1 o..
View full abstractGrants
Awarded by Bill and Melinda Gates Foundation
Funding Acknowledgements
This work is supported by the National Health and Medical Research Council of Australia (grant no. 566792) and the Bill and Melinda Gates Foundation (grant no. OPP1116833). The doses of PCV10 and funding for the opsonophagocytic assays are provided by GlaxoSmithKline Biologicals SA (GSK).